PADCEV
- Product NDC
- 51144-030
- 11-digit product format
- 511440030
- Labeler code
- 51144
- Product ID
- 51144-030_33307968-30bb-4890-8163-a24aec6b4520
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- ENFORTUMAB VEDOTIN
- Dosage form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- INTRAVENOUS
- Labeler
- SEAGEN INC.
- Application
- BLA761137
- Marketing category
- BLA
- Marketing start
- 2019-12-18
- Substance
- ENFORTUMAB VEDOTIN
- Active strength
- 30 mg/3mL
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- PADCEV
- Brand name suffix
- EJFV
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| ENFORTUMAB VEDOTIN | 30 mg/3mL |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | DLE8519RWM |
| Rxcui | 2268311, 2268315, 2268317, 2268319 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 51144-030-01 | PADCEVEJFV | 3 mL in 1 VIAL, SINGLE-DOSE | INJECTION, POWDER, LYOPHILIZED, | 3 | | 16 |
| 51144-030-01 | PADCEVEJFV | 1 in 1 BOX | INJECTION, POWDER, LYOPHILIZED, | 1 | | 16 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 51144-030 | PADCEV EJFV (ENFORTUMAB VEDOTIN) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [SEAGEN INC.] | 15 | Current NDC, Legacy NDC, 2 package rows | 20250316_b5631d3e-4604-4363-8f20-11dfc5a4a8ed.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 51144-030-01 | 51144003001 | 1 VIAL, SINGLE-DOSE in 1 BOX (51144-030-01) / 3 mL in 1 VIAL, SINGLE-DOSE | 2019-12-18 | 0000-00-00 | No | No | Current |